• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    West Pharmaceutical Services (NY: WST )

    287.85 -5.17 (-1.76%)
    Official Closing Price Updated: 7:00 PM EDT, Aug 9, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 886,489
    Open 292.43
    Bid (Size) 276.85 (1)
    Ask (Size) 302.19 (1)
    Prev. Close 293.02
    Today's Range 283.18 - 294.36
    52wk Range 265.00 - 415.73
    Shares Outstanding 73,500,000
    Dividend Yield 0.26%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Balancing Dividends and Fundamentals: The Case of NYSE:WST.
    Why the dividend investor may take a look at WEST PHARMACEUTICAL SERVICES (NYSE:WST). 
    Via Chartmill
    Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
    Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),... 
    Via Benzinga

    Performance

    YTD
    -17.45%
    -17.45%
    1 Month
    -13.64%
    -13.64%
    3 Month
    -19.63%
    -19.63%
    6 Month
    -29.21%
    -29.21%
    1 Year
    -27.08%
    -27.08%

    More News

    Read More
    WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Why NYSE:WST is a Top Pick for Dividend Investors.
    Via Chartmill
    How Is The Market Feeling About West Pharmaceutical Servs?
    Via Benzinga
    Uncovering Dividend Opportunities with NYSE:WST.
    Via Chartmill
    Peering Into West Pharmaceutical Servs's Recent Short Interest
    Via Benzinga
    How Is The Market Feeling About West Pharmaceutical Servs?
    Via Benzinga
    Why the dividend investor may take a look at NYSE:WST.
    Via Chartmill
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    (WST) - Analyzing West Pharmaceutical Servs's Short Interest
    Via Benzinga
    Exploring NYSE:WST's dividend characteristics.
    Via Chartmill
    Analyzing NYSE:WST's Dividend Potential.
    Via Chartmill
    (WST) - Analyzing West Pharmaceutical Servs's Short Interest
    Via Benzinga
    3 Pharma Stocks to Sell in March Before They Crash & Burn
    Via InvestorPlace
    S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
    Via Benzinga
    West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75
    Via Talk Markets
    Earnings Scheduled For February 15, 2024
    Via Benzinga
    Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a quality stock.
    Via Chartmill
    Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here's What You Need To Know
    Via Benzinga
    TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'
    Via Benzinga
    Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 10 Years
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.